Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.73 [0.6-0.89],0.00203990926710883,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.06 [1.02-1.1],0.00289312459801056,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REN,Renin,Inverse variance weighted,4,1.17 [1.05-1.3],0.00355671809400496,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.39 [0.21-0.74],0.00369077455704805,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.88 [0.81-0.96],0.00407328976412414,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.64 [0.47-0.87],0.00498844498749494,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.09 [1.02-1.15],0.00790227604732393,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.05 [1.01-1.1],0.0173648865457357,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.93 [0.87-0.99],0.0203256081751147,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.12 [1.02-1.23],0.0217380428335786,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.92 [0.86-0.99],0.0228420074594537,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.75 [0.58-0.97],0.0270212149481867,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BGLAP,Osteocalcin,Inverse variance weighted,2,0.63 [0.41-0.95],0.0285235645826359,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.8 [0.65-0.98],0.0328061103622856,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.95 [0.9-1],0.0353196021725439,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AREG,Amphiregulin,Inverse variance weighted,3,0.82 [0.68-0.99],0.0400485774724659,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.9 [0.81-1],0.0410496575397012,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.29 [1.01-1.66],0.0450764301647375,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.69 [1-2.85],0.0479380831297901,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.7 [0.5-1],0.048319000127361,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.43 [0.19-1],0.0490495922482426,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD276,CD276 antigen,Inverse variance weighted,20,0.95 [0.91-1],0.0491180039406984,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.87 [0.75-1],0.0574105902845713,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.59 [0.98-2.56],0.0596685611844396,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.96 [0.92-1],0.0618254920972336,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.8 [0.63-1.02],0.0674944949298337,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.03 [1-1.06],0.0698148991256972,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.97 [0.94-1],0.0700326915860603,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.03 [1-1.07],0.0707811920040802,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.85 [0.71-1.02],0.0751110627969098,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS9,Galectin-9,Inverse variance weighted,26,1.06 [0.99-1.14],0.0777235715901191,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.96 [0.91-1.01],0.0827279951296291,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.93 [0.85-1.01],0.0890806466483937,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.1 [0.99-1.22],0.0900019517181245,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.76 [0.55-1.05],0.0919344884468391,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.89 [0.78-1.02],0.0941624445851225,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,C7,Complement component C7,Inverse variance weighted,38,1.03 [0.99-1.07],0.0945109486690393,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.05 [0.99-1.12],0.0946540534546027,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.86 [0.71-1.03],0.0964597526718242,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.08 [0.99-1.18],0.0979849487621473,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NECTIN2,Nectin-2,Inverse variance weighted,5,0.93 [0.86-1.01],0.0989882428803893,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.94 [0.87-1.01],0.101291080493497,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.17 [0.97-1.42],0.101992570797241,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.05 [0.99-1.11],0.107496316307688,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.08 [0.98-1.19],0.110493126372872,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.11 [0.98-1.27],0.110894473537945,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.1 [0.98-1.25],0.11558736924348,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SDC1,Syndecan-1,Inverse variance weighted,2,1.18 [0.96-1.46],0.116363921581424,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.96 [0.92-1.01],0.116754672659372,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.92 [0.84-1.02],0.117208855975504,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.92 [0.82-1.02],0.121887249401239,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.13 [0.97-1.33],0.123137233164826,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPP1,Osteopontin,Inverse variance weighted,8,0.85 [0.7-1.04],0.123966946327834,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.74 [0.5-1.09],0.126331795897289,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.92 [0.83-1.02],0.127497692428032,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.81 [0.61-1.07],0.133171385781611,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.95 [0.89-1.02],0.13625481294943,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.96 [0.92-1.01],0.139091486371712,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRSS8,Prostasin,Inverse variance weighted,5,0.86 [0.7-1.05],0.143825377592386,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.96 [0.91-1.01],0.14485997906793,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.93 [0.84-1.03],0.145711382679835,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GRN,Progranulin,Inverse variance weighted,7,0.93 [0.84-1.03],0.146517316722822,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MDK,Midkine,Inverse variance weighted,4,1.15 [0.95-1.4],0.146814709075594,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.94 [0.87-1.02],0.153010724810498,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NRP1,Neuropilin-1,Inverse variance weighted,12,1.07 [0.97-1.17],0.157721740093433,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.08 [0.97-1.2],0.158556370245043,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.95 [0.89-1.02],0.162756548523188,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.06 [0.98-1.14],0.164281591044984,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.82 [0.61-1.09],0.167368137168035,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.89 [0.75-1.05],0.168370065333014,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.12 [0.95-1.32],0.170202871798461,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.04 [0.99-1.09],0.17042411976055,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC3B,Tetranectin,Inverse variance weighted,7,0.92 [0.81-1.04],0.170653874620427,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.15 [0.94-1.4],0.170821393430652,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.13 [0.95-1.34],0.173531437626785,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.93 [0.85-1.03],0.174594580230391,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.94 [0.87-1.03],0.178354004799494,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.86 [0.69-1.07],0.178438914541858,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.96 [0.9-1.02],0.178813097193123,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PENK,Proenkephalin-A,Inverse variance weighted,19,1.05 [0.98-1.13],0.186641328137188,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.83 [0.63-1.09],0.190304318056749,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.97 [0.92-1.02],0.191183441586283,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.03 [0.98-1.08],0.193984298027691,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.66 [0.77-3.57],0.196384400929172,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.87 [0.71-1.07],0.197952998860866,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL15,Interleukin-15,Wald ratio,1,0.2 [0.02-2.33],0.200708517177887,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.16 [0.92-1.45],0.202474341569019,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.91 [0.78-1.05],0.203249106456281,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS4,Galectin-4,Inverse variance weighted,4,0.86 [0.69-1.08],0.204109222122407,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.09 [0.95-1.24],0.210550997809489,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.05 [0.97-1.15],0.215271652706719,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.95 [0.88-1.03],0.217430781883963,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.17 [0.91-1.51],0.218665248480036,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.06 [0.97-1.16],0.222926741574616,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [0.99-1.06],0.223668853910466,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.11 [0.94-1.32],0.224983659029482,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.86 [0.67-1.1],0.225264983747883,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.9 [0.75-1.07],0.227528385823203,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.34 [0.83-2.18],0.229530050403561,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.22 [0.88-1.69],0.2298850766331,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.1 [0.94-1.28],0.2343477809361,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN5,CCN family member 5,Inverse variance weighted,8,0.87 [0.69-1.09],0.234631064597856,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNC,Tenascin,Inverse variance weighted,12,1.06 [0.96-1.16],0.235042761573811,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPO,Erythropoietin,Inverse variance weighted,5,0.71 [0.41-1.25],0.236242760815173,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.09 [0.94-1.25],0.249475583851943,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN4,CCN family member 4,Inverse variance weighted,27,0.97 [0.91-1.02],0.250067335915732,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.93 [0.82-1.06],0.258612738873217,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.07 [0.95-1.2],0.25920134723723,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.92 [0.8-1.06],0.262026698026059,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.97 [0.91-1.03],0.263303999235455,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.11 [0.93-1.32],0.264987748834538,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.13 [0.91-1.4],0.26544322574425,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.06 [0.96-1.18],0.26819424443166,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1.03 [0.97-1.1],0.271608612448861,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.29 [0.82-2.02],0.276866450386759,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.93-1.02],0.27825684163148,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AMBP,Protein AMBP,Inverse variance weighted,3,1.11 [0.92-1.35],0.279604159933898,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.03 [0.97-1.09],0.281864959478986,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CALCA,Calcitonin,Inverse variance weighted,5,0.81 [0.56-1.19],0.283725909803462,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.95 [0.86-1.05],0.284508249554713,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CFD,Complement factor D,Inverse variance weighted,11,0.95 [0.87-1.04],0.28534072343162,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.03 [0.98-1.08],0.286001458132882,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [0.98-1.09],0.295420972103927,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NECTIN4,Nectin-4,Inverse variance weighted,7,1.06 [0.95-1.18],0.295896504815741,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.69 [0.35-1.38],0.296429146196176,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.13 [0.9-1.41],0.303063506635826,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBP2,Retinol-binding protein 2,Wald ratio,1,1.29 [0.79-2.08],0.307192568213431,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.05 [0.96-1.14],0.30998519307083,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.04 [0.96-1.12],0.311325046852509,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NFASC,Neurofascin,Inverse variance weighted,15,1.04 [0.97-1.11],0.313908351251153,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.05 [0.95-1.16],0.315273977872716,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.27 [0.8-2.03],0.317131802800293,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.88 [0.68-1.13],0.31844176829584,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COLEC12,Collectin-12,Inverse variance weighted,11,0.95 [0.85-1.06],0.325180346382215,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.04 [0.96-1.12],0.325839480355689,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.97 [0.92-1.03],0.331257253555845,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.04 [0.96-1.14],0.3352148468652,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,0.93 [0.8-1.08],0.338612229077931,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.9 [0.72-1.12],0.3418625208535,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,0.94 [0.83-1.07],0.34463251406395,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.84 [0.57-1.22],0.349312387431198,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.93-1.23],0.349838756047743,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP7,Matrilysin,Inverse variance weighted,13,1.04 [0.96-1.12],0.350258305673524,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.15 [0.85-1.56],0.353979745332654,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OCLN,Occludin,Inverse variance weighted,2,1.11 [0.89-1.39],0.355917425444683,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,0.97 [0.89-1.04],0.356382105395929,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.04 [0.95-1.14],0.359379091724018,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.71 [0.33-1.5],0.364953941701195,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1.03 [0.96-1.11],0.368907102554799,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.02 [0.97-1.08],0.370791296679213,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.96 [0.86-1.06],0.37236013751861,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.03 [0.97-1.09],0.373749956404432,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.96-1.1],0.383082795952995,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.91 [0.75-1.12],0.385151502269028,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.98 [0.94-1.03],0.389254293417332,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP10,Stromelysin-2,Inverse variance weighted,22,0.96 [0.89-1.05],0.389496447966843,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.04 [0.95-1.15],0.390296366271733,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.93-1.03],0.390718964780062,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.83 [0.54-1.28],0.391375421784226,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.96 [0.87-1.05],0.391630963946079,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.08 [0.91-1.27],0.398266594627038,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLK4,Kallikrein-4,Inverse variance weighted,17,1.03 [0.96-1.09],0.398803034629415,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SEPTIN8,Septin-8,Inverse variance weighted,2,0.85 [0.59-1.24],0.400925239424975,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.02 [0.97-1.08],0.401707071183077,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.95 [0.83-1.08],0.404966879278075,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.94-1.16],0.407369442950345,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.33 [0.68-2.61],0.409294305011834,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.98-1.05],0.414825801702749,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CTSL,Cathepsin L1,Wald ratio,1,1.3 [0.69-2.46],0.416613974314361,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [0.97-1.06],0.418468264591874,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD160,CD160 antigen,Inverse variance weighted,11,1.03 [0.95-1.12],0.427274284518404,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN3,CCN family member 3,Inverse variance weighted,19,1.04 [0.95-1.13],0.429146249935296,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.22 [0.74-2.01],0.432219140945548,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.03 [0.95-1.12],0.432310869958358,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.03 [0.95-1.12],0.436137798404294,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.96 [0.85-1.07],0.438036163365468,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.02 [0.98-1.05],0.440000412075101,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.06 [0.92-1.23],0.440268496175325,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.03 [0.95-1.13],0.455999908100525,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.94 [0.78-1.12],0.464290592940296,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.91 [0.71-1.17],0.467030690830651,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.03 [0.95-1.11],0.468645819362898,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.03 [0.96-1.1],0.470035633278193,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.95 [0.82-1.09],0.479388305441577,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.94-1.03],0.479796095207042,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.97 [0.89-1.06],0.484464910947135,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.02 [0.97-1.06],0.486973238532374,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.94-1.03],0.489071121830339,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.98 [0.92-1.04],0.492127477156344,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.03 [0.95-1.11],0.515301641546591,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.94 [0.78-1.13],0.515923637968753,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPON2,Spondin-2,Inverse variance weighted,4,1.05 [0.91-1.2],0.521933554439961,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.97 [0.87-1.07],0.525538139487337,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.05 [0.91-1.2],0.528459610005599,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DSC2,Desmocollin-2,Inverse variance weighted,9,1.03 [0.93-1.14],0.532634783378859,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.05 [0.91-1.2],0.534493139823612,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.96 [0.86-1.08],0.536121752311065,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.98 [0.91-1.05],0.540804896890693,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.93 [0.74-1.17],0.542472871091958,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [0.96-1.09],0.546589240179831,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.97 [0.88-1.07],0.547693885762642,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.78 [0.35-1.75],0.548024412659409,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.9 [0.63-1.28],0.549192584939676,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.04 [0.91-1.18],0.555359097001483,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PSAP,Prosaposin,Inverse variance weighted,5,1.05 [0.88-1.26],0.558869173791771,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EDN1,Endothelin-1,Inverse variance weighted,3,1.04 [0.91-1.18],0.564502951673594,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VWC2,Brorin,Inverse variance weighted,22,0.98 [0.91-1.05],0.566010508368571,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD302,CD302 antigen,Inverse variance weighted,9,0.97 [0.88-1.07],0.568104109615533,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.06 [0.87-1.29],0.570421811301433,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.21 [0.63-2.34],0.57107767453104,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.98 [0.9-1.06],0.571483044780139,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.1 [0.79-1.51],0.57639252003574,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,F10,Coagulation factor X,Inverse variance weighted,9,1.01 [0.96-1.07],0.578136175159703,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS1,Galectin-1,Inverse variance weighted,6,0.98 [0.89-1.06],0.581721657088986,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.93-1.04],0.584461436523148,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.95 [0.78-1.15],0.584465748700549,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL19,Interleukin-19,Inverse variance weighted,11,1.02 [0.94-1.12],0.5857233461926,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.98 [0.92-1.05],0.595283626667142,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.03 [0.93-1.13],0.597968711244621,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.93-1.04],0.60021726012652,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.07 [0.82-1.41],0.615104241272857,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.12 [0.71-1.78],0.616925988466445,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.03 [0.92-1.15],0.617415054865042,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.94-1.11],0.617643115409621,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.98 [0.9-1.07],0.621320686710402,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.05 [0.88-1.24],0.621795635440706,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.93 [0.7-1.24],0.622081983973231,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.14 [0.67-1.93],0.625976909880536,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.03 [0.92-1.15],0.63211368543353,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.95-1.08],0.634948391067382,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.84 [0.4-1.75],0.635061141303149,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD27,CD27 antigen,Inverse variance weighted,9,1.02 [0.94-1.11],0.642159141657092,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.95 [0.75-1.2],0.644130533204363,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.08 [0.78-1.5],0.645177560984587,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.94 [0.71-1.24],0.646597104694405,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.92 [0.66-1.3],0.647799117932981,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCG2,Secretogranin-2,Wald ratio,1,1.15 [0.62-2.14],0.659315844380071,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.98 [0.88-1.09],0.663649037163856,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD83,CD83 antigen,Inverse variance weighted,5,0.97 [0.83-1.12],0.663692780548904,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCAN,Neurocan core protein,Inverse variance weighted,3,0.96 [0.79-1.16],0.663793792268235,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.98 [0.92-1.06],0.664809621558913,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.01 [0.97-1.05],0.667770861853736,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.98 [0.9-1.07],0.669665633914967,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.96 [0.81-1.15],0.671541059745672,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PI3,Elafin,Inverse variance weighted,10,1.03 [0.91-1.16],0.67585955795828,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.96 [0.8-1.15],0.676736662093575,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FBLN2,Fibulin-2,Inverse variance weighted,11,0.98 [0.91-1.06],0.676915614167823,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,0.99 [0.93-1.05],0.677057453176393,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.03 [0.9-1.18],0.681357725654254,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.01 [0.96-1.06],0.684362881477583,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL17C,Interleukin-17C,Inverse variance weighted,3,1.05 [0.84-1.3],0.686071168568127,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MB,Myoglobin,Wald ratio,1,0.85 [0.39-1.86],0.687541762052217,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AGRN,Agrin,Inverse variance weighted,17,1.02 [0.92-1.14],0.691527724374504,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CALB2,Calretinin,Wald ratio,1,1.1 [0.68-1.78],0.694176686208185,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.02 [0.94-1.1],0.698087630641437,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRSS2,Trypsin-2,Inverse variance weighted,3,0.96 [0.8-1.16],0.705801598855184,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.01 [0.95-1.07],0.708289692507741,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,F7,Coagulation factor VII,Inverse variance weighted,21,0.99 [0.93-1.05],0.716923926753981,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PALM2,Paralemmin-2,Inverse variance weighted,8,0.98 [0.87-1.1],0.720083262961039,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.98 [0.86-1.11],0.722131863251352,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.02 [0.89-1.18],0.724940064838214,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.93 [0.62-1.4],0.725586831995657,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.98 [0.86-1.11],0.726646514052262,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,0.97 [0.84-1.13],0.728463132392625,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MATN2,Matrilin-2,Inverse variance weighted,18,1.02 [0.93-1.12],0.731481727131345,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.94 [0.66-1.35],0.736011587611601,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.01 [0.95-1.07],0.737577034327002,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.03 [0.85-1.25],0.737654575077421,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.99 [0.92-1.06],0.741442616277972,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OGN,Mimecan,Inverse variance weighted,30,1.01 [0.95-1.07],0.744538009419071,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.97 [0.83-1.14],0.745794704851388,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.01 [0.93-1.11],0.75173779992263,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.01 [0.96-1.06],0.754950921775513,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RSPO1,R-spondin-1,Inverse variance weighted,5,0.98 [0.87-1.11],0.762885838152377,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RSPO3,R-spondin-3,Inverse variance weighted,6,1.04 [0.83-1.3],0.765111815475975,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.95-1.07],0.768770229885541,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.97 [0.81-1.17],0.774554218628809,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.01 [0.92-1.12],0.777592022089589,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.92-1.07],0.778000022501019,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.01 [0.94-1.09],0.787532494672787,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.04 [0.8-1.35],0.787851626836186,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.99 [0.89-1.1],0.790921672254423,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.03 [0.85-1.24],0.79570509920039,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.98 [0.84-1.14],0.798886429228489,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.03 [0.83-1.28],0.80023733341522,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.89-1.16],0.809808951397838,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.02 [0.89-1.15],0.811725273209286,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.97 [0.72-1.3],0.817498183240555,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.99 [0.89-1.09],0.818973431969602,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.99 [0.89-1.1],0.822738863220726,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.99 [0.93-1.06],0.822880051242077,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.03 [0.8-1.32],0.823923832671338,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.94-1.05],0.833023526923757,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1 [0.97-1.03],0.834753357984421,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.98 [0.81-1.18],0.837902334809994,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.94-1.05],0.838341649306287,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MUC13,Mucin-13,Inverse variance weighted,9,0.99 [0.86-1.13],0.838780663314734,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.96-1.05],0.840010943491577,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.01 [0.92-1.1],0.846498494508229,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.99 [0.92-1.07],0.847025468525015,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.02 [0.85-1.21],0.854606625327206,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.98 [0.74-1.28],0.861945900936046,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.99 [0.9-1.09],0.862081658422984,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.97 [0.7-1.35],0.862656371104342,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.01 [0.92-1.1],0.867452490109313,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.99 [0.89-1.11],0.867487151775297,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.92-1.08],0.867607564060692,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.98 [0.74-1.29],0.8716938791217,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.99 [0.9-1.1],0.877451714563329,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.98 [0.74-1.3],0.883094652792497,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ELN,Elastin,Inverse variance weighted,2,0.97 [0.64-1.48],0.88505192954484,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHGA,Chromogranin-A,Inverse variance weighted,3,1.01 [0.87-1.17],0.888298951716013,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.75-1.28],0.891931285424027,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.96 [0.56-1.67],0.895250971931766,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.03 [0.69-1.52],0.897068369995847,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.99 [0.89-1.11],0.897167141110083,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.04 [0.61-1.77],0.897895319530349,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.99 [0.88-1.12],0.898964477137255,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.93-1.09],0.901021944155106,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RETN,Resistin,Inverse variance weighted,9,1 [0.94-1.07],0.903399914227213,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.01 [0.92-1.1],0.905386790110956,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.88-1.15],0.911343576308413,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SERPINA11,Serpin A11,Inverse variance weighted,31,1 [0.95-1.05],0.913116671345736,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BSG,Basigin,Wald ratio,1,0.99 [0.8-1.22],0.913840153866729,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.93-1.07],0.915023503709036,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.98 [0.69-1.4],0.920000897672456,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.01 [0.85-1.2],0.925831096671304,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.99 [0.85-1.16],0.927504053301287,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.99 [0.83-1.19],0.929001806612604,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.02 [0.7-1.48],0.930633801649033,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.99 [0.69-1.41],0.935138795393572,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.01 [0.81-1.25],0.939803941605225,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.01 [0.87-1.16],0.941354085835651,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1 [0.89-1.14],0.94172983772445,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.99 [0.86-1.15],0.942046913326128,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.88-1.15],0.943060599037711,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PGF,Placenta growth factor,Inverse variance weighted,2,0.97 [0.46-2.05],0.946653194924178,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BCAN,Brevican core protein,Inverse variance weighted,3,1.01 [0.82-1.23],0.956751938687085,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PTN,Pleiotrophin,Inverse variance weighted,4,1.01 [0.65-1.57],0.956769516501535,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.01 [0.82-1.24],0.959652872771859,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LMNB2,Lamin-B2,Wald ratio,1,1.02 [0.5-2.09],0.962434160754821,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.01 [0.74-1.36],0.966297162548013,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP3,Stromelysin-1,Inverse variance weighted,34,1 [0.94-1.07],0.972264204963106,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1 [0.85-1.17],0.97554894045237,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1 [0.95-1.06],0.975718010177809,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.93-1.08],0.978040266098242,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.99 [0.45-2.19],0.978350106413405,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1 [0.87-1.16],0.97836905424154,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1 [0.82-1.23],0.98055173379751,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.95-1.05],0.989591749671564,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.96-1.05],0.990194964426843,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1 [0.86-1.16],0.994286302701635,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1 [0.96-1.04],0.994923755341284,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1 [0.87-1.14],0.998520518338094,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1 [0.65-1.54],0.998872185123864,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1 [0.88-1.14],0.999530849152187,cis
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.12 [1.05-1.2],0.00102887692029239,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,2.16 [1.34-3.49],0.00169275961428021,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.55 [0.37-0.82],0.0029638941642017,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.64 [0.47-0.88],0.00567077391820453,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.85 [0.75-0.95],0.00627388018497962,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WNT9A,Protein Wnt-9a,Wald ratio,1,3.15 [1.37-7.21],0.00668806861947927,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.48 [1.11-1.96],0.00704752095688815,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,2.36 [1.24-4.48],0.00885417967237869,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.08 [1.02-1.15],0.0123735516113011,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.44 [1.08-1.91],0.0129073338288725,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.16 [1.16-4.01],0.0145794085876486,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.8 [0.67-0.96],0.0147997022228015,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.44 [0.21-0.89],0.0229877268512554,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.7 [0.51-0.95],0.0240909038095025,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.85 [0.74-0.98],0.0251005167278149,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.66 [0.45-0.95],0.025451249858685,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.64 [0.43-0.95],0.0272123066785883,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.63 [1.04-2.56],0.0313522537698342,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.85 [0.74-0.99],0.0340699951929636,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.92 [0.84-0.99],0.0360591084415831,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.46 [1.02-2.09],0.03647052469299,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SERPINA11,Serpin A11,Inverse variance weighted,14,1.24 [1.01-1.52],0.0364973825680112,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.82 [0.68-0.99],0.0365170232916788,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.24 [1.01-1.51],0.037521230688087,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.64 [0.42-0.98],0.0381817311581358,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,F10,Coagulation factor X,Inverse variance weighted,11,0.88 [0.78-0.99],0.039946636242797,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.5 [0.25-0.97],0.0409042174610975,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.23 [1.01-1.51],0.0437940093891667,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHGA,Chromogranin-A,Inverse variance weighted,5,1.25 [1-1.55],0.0469695107569326,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.87 [0.77-1],0.0478245117233098,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.12 [1-1.26],0.0550625907624564,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.76 [0.57-1.01],0.0584553673445559,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.15 [0.99-1.33],0.0601677273125339,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.06 [1-1.13],0.0624720180145749,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCG2,Secretogranin-2,Inverse variance weighted,2,1.42 [0.98-2.05],0.0627806106229896,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS9,Galectin-9,Inverse variance weighted,36,1.06 [1-1.12],0.0680653902536727,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.06 [1-1.12],0.0700348370455054,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PENK,Proenkephalin-A,Inverse variance weighted,15,1.12 [0.99-1.27],0.0730991563135283,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.91 [0.82-1.01],0.0738823763713015,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP7,Matrilysin,Wald ratio,1,0.78 [0.6-1.03],0.0772066592985365,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.78 [0.59-1.03],0.0780712835127117,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.83 [0.68-1.02],0.078183130371888,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.31 [0.97-1.77],0.0803133040235715,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.21 [0.97-1.49],0.0844921684407356,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.89 [0.79-1.02],0.0847686221638379,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.77 [0.57-1.04],0.0856483264913069,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.68 [0.44-1.06],0.0867304130042898,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AMBP,Protein AMBP,Inverse variance weighted,5,1.17 [0.98-1.39],0.0869154453689423,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.37 [0.95-1.97],0.088555303003424,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.08 [0.99-1.18],0.0887177333911493,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNC,Tenascin,Inverse variance weighted,57,1.04 [0.99-1.09],0.0890535910920424,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CST3,Cystatin-C,Inverse variance weighted,3,0.62 [0.36-1.08],0.0920128097705156,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.15 [0.98-1.36],0.0925674775828683,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.72 [0.49-1.06],0.0932858440607781,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL15,Interleukin-15,Inverse variance weighted,35,0.93 [0.85-1.01],0.0933256512496651,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.91 [0.82-1.02],0.0973281299373755,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PGF,Placenta growth factor,Inverse variance weighted,5,1.22 [0.96-1.54],0.0993653778069456,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.16 [0.97-1.4],0.105768152864476,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN5,CCN family member 5,Inverse variance weighted,12,0.92 [0.83-1.02],0.107045617311359,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.61 [0.33-1.12],0.10830359661641,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.04 [0.99-1.1],0.12231926076329,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.3 [0.93-1.81],0.122558256127317,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.95 [0.9-1.01],0.123698268828693,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.1 [0.97-1.24],0.124559028525466,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.15 [0.96-1.37],0.132721259184303,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.96 [0.9-1.01],0.134431465835299,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.31 [0.91-1.87],0.141459943638752,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.07 [0.98-1.17],0.142331516346927,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.68 [0.4-1.15],0.148154986966628,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.49 [0.86-2.57],0.151141476050598,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.07 [0.97-1.18],0.151159391170728,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.91 [0.8-1.03],0.151376841041071,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.05 [0.98-1.14],0.159960254948642,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.84 [0.65-1.07],0.161417582230294,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.04 [0.99-1.09],0.162752004843859,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.8 [0.58-1.1],0.16386593741021,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.93 [0.84-1.03],0.164091164901758,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.14 [0.95-1.36],0.164278685263494,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.68 [0.4-1.18],0.17531323388471,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.17 [0.93-1.48],0.177925864540961,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,XCL1,Lymphotactin,Inverse variance weighted,15,0.89 [0.75-1.06],0.178954384214429,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MDK,Midkine,Inverse variance weighted,14,1.11 [0.95-1.3],0.183227355354557,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.06 [0.97-1.16],0.187475182273554,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.94 [0.87-1.03],0.189842811479838,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.82 [0.61-1.11],0.190343166417205,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.87 [0.7-1.08],0.198272415711583,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.86 [0.68-1.08],0.198698813684683,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.97-1.16],0.201721434815353,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.39 [0.84-2.29],0.20472792110031,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.1 [0.95-1.27],0.215424695563873,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL22,Interleukin-22,Inverse variance weighted,4,0.69 [0.39-1.24],0.217866521694834,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.9 [0.76-1.07],0.219436275137202,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.83 [0.62-1.12],0.225383900293276,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.15 [0.91-1.46],0.22621414673213,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.12 [0.93-1.34],0.227538400123415,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN3,CCN family member 3,Inverse variance weighted,17,1.05 [0.97-1.15],0.227591167309162,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.34 [0.83-2.18],0.229530050403561,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.23 [0.88-1.74],0.229634065722455,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.88 [0.71-1.09],0.231456223369345,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.09 [0.94-1.26],0.232872855457514,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,F7,Coagulation factor VII,Inverse variance weighted,10,0.9 [0.75-1.07],0.233832478110356,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OCLN,Occludin,Inverse variance weighted,2,1.28 [0.85-1.92],0.237174147893407,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.76 [0.48-1.2],0.239848282469352,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.21 [0.88-1.66],0.24242477888411,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.97 [0.91-1.02],0.249628267650753,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DSC2,Desmocollin-2,Inverse variance weighted,16,1.05 [0.96-1.15],0.250126099539495,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.91 [0.77-1.07],0.25138512539727,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPO,Erythropoietin,Inverse variance weighted,11,0.94 [0.84-1.05],0.251619477570047,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD160,CD160 antigen,Inverse variance weighted,24,1.07 [0.95-1.2],0.253859830727888,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.69 [0.35-1.32],0.260172935811839,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.72 [0.41-1.28],0.262974503452952,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RSPO1,R-spondin-1,Inverse variance weighted,8,1.14 [0.91-1.43],0.263795710896493,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.1 [0.93-1.3],0.267410239851493,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.89 [0.71-1.1],0.27001646853054,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.14 [0.9-1.45],0.270341244883584,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,0.95 [0.86-1.04],0.271328228427111,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.87 [0.69-1.11],0.272218390794613,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.88 [0.71-1.1],0.272234139933779,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.21 [0.86-1.71],0.274797299803317,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.06 [0.96-1.17],0.275844651371677,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.1 [0.93-1.3],0.281179923262902,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.88 [0.7-1.11],0.289611968196957,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.85 [0.62-1.15],0.29039322476956,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.21 [0.85-1.73],0.296531029309659,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.85 [0.62-1.16],0.29960218873601,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.97 [0.92-1.03],0.302444230485857,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MATN2,Matrilin-2,Inverse variance weighted,28,1.03 [0.98-1.08],0.303137390447822,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.86 [0.65-1.15],0.311032464222979,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.87 [0.67-1.14],0.313400206713139,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.9 [0.74-1.1],0.314099252522247,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.1 [0.91-1.32],0.314161954553928,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PSAP,Prosaposin,Inverse variance weighted,13,1.05 [0.95-1.16],0.318841893918557,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,0.7 [0.34-1.42],0.320071906253811,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.07 [0.94-1.21],0.322130803749817,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.21 [0.83-1.77],0.325753159782399,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.91 [0.76-1.1],0.329174875522759,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REN,Renin,Inverse variance weighted,8,0.89 [0.71-1.12],0.329808023863091,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.1 [0.91-1.32],0.337128537013058,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.91 [0.76-1.1],0.340420298072344,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.28 [0.77-2.15],0.344649685656474,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.93-1.23],0.349838756047743,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CTSL,Cathepsin L1,Inverse variance weighted,29,0.95 [0.86-1.05],0.352626684850339,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.85-1.06],0.353622872755512,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SDC1,Syndecan-1,Inverse variance weighted,12,1.07 [0.93-1.24],0.354808480502062,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.86 [0.62-1.19],0.357986108489476,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.08 [0.91-1.28],0.359165887698455,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.81 [0.53-1.26],0.36022130371545,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.91 [0.75-1.11],0.361349234254622,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.95 [0.84-1.07],0.366105690615226,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.14 [0.86-1.51],0.367286506666653,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.13 [0.87-1.46],0.36876180307251,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.12 [0.87-1.45],0.369094525211644,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.08 [0.91-1.28],0.37153138519531,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.87 [0.64-1.19],0.374539200595792,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.07 [0.92-1.25],0.374865885987973,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PI3,Elafin,Inverse variance weighted,18,1.04 [0.95-1.15],0.377892948945735,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.14 [0.85-1.54],0.380796132912123,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.09 [0.9-1.32],0.382324459486445,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.07 [0.92-1.24],0.388623505475074,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD99,CD99 antigen,Inverse variance weighted,4,1.13 [0.85-1.51],0.389680218908058,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.38 [0.66-2.89],0.392753497229107,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.93 [0.77-1.11],0.397604266728127,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.15 [0.83-1.6],0.406010670178771,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.83 [0.53-1.3],0.40829433814059,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.12 [0.86-1.45],0.408672972397407,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.18 [0.79-1.76],0.414242734162652,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPON2,Spondin-2,Inverse variance weighted,3,0.8 [0.46-1.38],0.419122759332421,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ELN,Elastin,Inverse variance weighted,10,0.9 [0.71-1.16],0.419679781428178,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.81 [0.5-1.34],0.420045049686884,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.91 [0.72-1.15],0.422495253647454,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPP1,Osteopontin,Inverse variance weighted,13,1.08 [0.9-1.29],0.422798467930371,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.05 [0.93-1.2],0.423520499630461,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.08 [0.89-1.33],0.428906591414413,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,POF1B,Protein POF1B,Inverse variance weighted,4,1.11 [0.86-1.44],0.431681927247236,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL19,Interleukin-19,Inverse variance weighted,10,1.03 [0.95-1.13],0.431901168732378,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.02 [0.97-1.07],0.43293000560393,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.02 [0.96-1.09],0.434072178401906,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.85 [0.57-1.27],0.434893979213208,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.1 [0.87-1.39],0.434965062937359,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.95 [0.82-1.09],0.438209986357123,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,C7,Complement component C7,Inverse variance weighted,26,1.03 [0.96-1.1],0.441858950577865,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD83,CD83 antigen,Inverse variance weighted,14,1.08 [0.89-1.29],0.442010391933958,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.92-1.04],0.447828680612309,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.05 [0.93-1.17],0.448771153126805,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.97 [0.89-1.05],0.452574000455876,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RETN,Resistin,Inverse variance weighted,19,0.94 [0.81-1.1],0.45937999737853,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.14 [0.8-1.63],0.461797988138639,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NRP1,Neuropilin-1,Inverse variance weighted,14,0.94 [0.8-1.11],0.463384834196186,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COLEC12,Collectin-12,Inverse variance weighted,3,1.2 [0.73-1.96],0.46676805239456,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NECTIN4,Nectin-4,Inverse variance weighted,4,0.88 [0.63-1.23],0.467000954039392,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.44 [0.54-3.83],0.468758008173346,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD302,CD302 antigen,Inverse variance weighted,11,0.95 [0.83-1.09],0.474810220658579,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.05 [0.91-1.21],0.48425750107437,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.84 [0.51-1.38],0.493863161964595,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.87 [0.59-1.29],0.495536109564523,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.88 [0.6-1.28],0.496016013208711,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BSG,Basigin,Inverse variance weighted,6,1.1 [0.83-1.46],0.497732015427823,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.96 [0.85-1.08],0.497869788295429,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.07 [0.87-1.32],0.500841351579787,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PTN,Pleiotrophin,Inverse variance weighted,3,0.83 [0.47-1.44],0.501621872085778,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.04 [0.92-1.19],0.50828758365136,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.06 [0.89-1.25],0.514666817447931,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.14 [0.76-1.7],0.52335102905556,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.05 [0.91-1.2],0.530320526400369,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.02 [0.96-1.08],0.532240684013527,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD27,CD27 antigen,Inverse variance weighted,9,0.93 [0.73-1.18],0.532392596305033,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.94-1.12],0.532933515049616,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.92-1.18],0.539227922866409,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FBLN2,Fibulin-2,Inverse variance weighted,6,1.08 [0.85-1.37],0.543877333692602,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.91 [0.66-1.24],0.545527329255775,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRSS8,Prostasin,Inverse variance weighted,14,0.96 [0.83-1.1],0.546641462907147,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,1.11 [0.8-1.54],0.54809698808876,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.14 [0.75-1.72],0.551525951403235,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.07 [0.86-1.34],0.552325263410007,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,1.03 [0.94-1.12],0.552908836718623,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.96 [0.85-1.09],0.554342980546071,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.04 [0.92-1.17],0.558536843154489,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.92 [0.68-1.24],0.564734254670209,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.91 [0.68-1.24],0.566076961060221,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.09 [0.8-1.49],0.567250522927378,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.92 [0.69-1.23],0.572095907815696,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL17C,Interleukin-17C,Inverse variance weighted,5,1.09 [0.81-1.45],0.572549371309991,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.95 [0.8-1.13],0.575240813805637,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.89 [0.6-1.33],0.576338394395038,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.77 [0.31-1.93],0.579002782566637,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.95 [0.8-1.13],0.580576875606692,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL6,Interleukin-6,Inverse variance weighted,6,0.96 [0.83-1.11],0.58179275829159,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CSTB,Cystatin-B,Inverse variance weighted,23,1.02 [0.96-1.08],0.582694665964899,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.03 [0.92-1.16],0.587518965484022,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.02 [0.94-1.12],0.592386865918345,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MUC13,Mucin-13,Inverse variance weighted,3,1.11 [0.75-1.66],0.600473938947402,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.8 [0.34-1.89],0.606145484764056,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.94 [0.72-1.21],0.610570548164198,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.84 [0.42-1.66],0.61150264794823,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.1 [0.75-1.62],0.612253111771146,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.08 [0.81-1.43],0.616503217457567,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.06 [0.85-1.32],0.62387130403855,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.98 [0.89-1.07],0.625523599159486,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP10,Stromelysin-2,Wald ratio,1,1.2 [0.57-2.53],0.626503612694516,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS4,Galectin-4,Inverse variance weighted,15,1.02 [0.95-1.1],0.627817036889,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.88 [0.54-1.46],0.629949246313595,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,0.97 [0.86-1.1],0.639084142548892,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.04 [0.88-1.22],0.640623489114449,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.02 [0.94-1.11],0.643555843724033,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MB,Myoglobin,Inverse variance weighted,9,1.07 [0.8-1.43],0.645901910976284,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.88 [0.51-1.52],0.648749093839922,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.94-1.11],0.655923706003433,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.16 [0.59-2.29],0.661251764969954,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,VWC2,Brorin,Inverse variance weighted,12,1.04 [0.86-1.26],0.661866128388149,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.02 [0.92-1.13],0.663238329687509,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,0.97 [0.85-1.11],0.666872710163417,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,0.96 [0.8-1.16],0.667084748695596,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SEPTIN8,Septin-8,Inverse variance weighted,4,0.94 [0.7-1.25],0.667361041029654,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLK4,Kallikrein-4,Inverse variance weighted,5,0.9 [0.55-1.47],0.668582462801728,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.94 [0.69-1.27],0.66871411655166,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CFD,Complement factor D,Wald ratio,1,1.14 [0.62-2.12],0.669790579590767,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.04 [0.86-1.27],0.669972908180994,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.13 [0.64-2],0.670205005251594,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.95 [0.73-1.22],0.673612235082357,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.05 [0.83-1.34],0.674584813345345,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.96 [0.79-1.17],0.675155973671662,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.05 [0.85-1.29],0.683012493229381,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.95 [0.75-1.21],0.688532845999954,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.16 [0.56-2.38],0.689306752915132,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.95 [0.73-1.23],0.690353709534752,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AREG,Amphiregulin,Inverse variance weighted,5,1.09 [0.71-1.68],0.69043941290165,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.99 [0.92-1.06],0.690684614562624,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CFP,Properdin,Inverse variance weighted,17,1.02 [0.92-1.13],0.691889010487239,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.08 [0.74-1.58],0.692210896130865,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NFASC,Neurofascin,Inverse variance weighted,6,0.95 [0.72-1.25],0.692339715139407,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.96 [0.77-1.19],0.694006752557036,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.97 [0.85-1.12],0.694690468959291,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.98 [0.88-1.09],0.701805512581323,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.93 [0.64-1.35],0.701845158929551,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.97 [0.85-1.12],0.703631384234834,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.95 [0.73-1.24],0.706868705403366,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PRSS2,Trypsin-2,Inverse variance weighted,17,0.98 [0.87-1.1],0.713275512577695,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.03 [0.89-1.19],0.722502911781038,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.93 [0.62-1.39],0.72373308044616,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.1 [0.64-1.91],0.724695958650306,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.03 [0.86-1.23],0.730641092100451,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.97-1.04],0.731202635571857,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.05 [0.78-1.42],0.732963539871393,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.98 [0.87-1.11],0.733336260426134,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.96 [0.78-1.19],0.737255014335211,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.04 [0.83-1.3],0.740310107443741,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.01 [0.93-1.11],0.741438726702256,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,XG,Glycoprotein Xg,Inverse variance weighted,2,0.9 [0.48-1.68],0.745911663685711,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.05 [0.77-1.43],0.749056010677216,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.02 [0.92-1.13],0.749826584249384,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.04 [0.82-1.32],0.751268031567899,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.07 [0.7-1.64],0.755116506287182,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.98 [0.89-1.09],0.763402938711224,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC3B,Tetranectin,Inverse variance weighted,2,0.92 [0.54-1.57],0.765964789258328,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.02 [0.89-1.17],0.767096762767377,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.98 [0.87-1.11],0.770772168520005,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.97 [0.77-1.21],0.77397435458133,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,UMOD,Uromodulin,Inverse variance weighted,34,1.01 [0.92-1.12],0.775685188658633,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.97 [0.79-1.19],0.778866311709473,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.99 [0.93-1.05],0.779277829471323,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPON1,Spondin-1,Inverse variance weighted,4,1.05 [0.74-1.5],0.782258748015378,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.06 [0.67-1.68],0.788309351193015,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.97 [0.81-1.18],0.791537234152483,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.94 [0.57-1.54],0.791736335082247,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.05 [0.73-1.5],0.792916174481862,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.06 [0.69-1.62],0.79446123004787,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.98 [0.84-1.14],0.796821277857806,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.06 [0.66-1.71],0.798957610146184,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.02 [0.87-1.19],0.799951137092769,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.99 [0.93-1.06],0.800747557139443,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.96-1.06],0.80129165828339,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.99 [0.93-1.06],0.807933733595889,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.98 [0.83-1.15],0.810701907645038,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCN4,CCN family member 4,Inverse variance weighted,29,1.01 [0.93-1.1],0.817771200771008,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.96 [0.68-1.36],0.819921895051905,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.01 [0.92-1.11],0.821505724190234,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RSPO3,R-spondin-3,Inverse variance weighted,5,1.05 [0.67-1.65],0.822682553961047,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.96 [0.65-1.41],0.823892241308297,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.05 [0.7-1.56],0.825362022071211,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KLK11,Kallikrein-11,Inverse variance weighted,13,1.02 [0.85-1.23],0.827682603628282,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CALCA,Calcitonin,Inverse variance weighted,13,0.98 [0.82-1.17],0.827816682969301,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LMNB2,Lamin-B2,Inverse variance weighted,8,0.97 [0.76-1.24],0.829709580080532,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,1.03 [0.75-1.42],0.83230511109244,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.97 [0.73-1.3],0.837611957172688,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.94-1.05],0.838890140257252,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.98 [0.84-1.15],0.841494996892653,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.92 [0.39-2.15],0.842193629919689,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.03 [0.78-1.36],0.848832196568728,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NCAN,Neurocan core protein,Inverse variance weighted,19,1.01 [0.89-1.15],0.84896188704082,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.01 [0.91-1.11],0.861006120260454,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BCAN,Brevican core protein,Inverse variance weighted,12,0.98 [0.81-1.19],0.863807042605997,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.02 [0.8-1.3],0.868018588323271,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.99 [0.9-1.09],0.872963097145329,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.02 [0.8-1.31],0.874508380099088,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.99 [0.82-1.18],0.877239764294447,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.02 [0.8-1.29],0.878595091217338,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.07 [0.44-2.58],0.880173695738797,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.02 [0.82-1.27],0.880444866436415,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.95-1.04],0.888315242217334,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NECTIN2,Nectin-2,Inverse variance weighted,3,1.06 [0.46-2.41],0.894147588131334,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1 [0.94-1.07],0.898111701680333,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.01 [0.81-1.27],0.904038597272134,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GUCA2A,Guanylin,Inverse variance weighted,7,1.01 [0.78-1.31],0.917791933764355,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.01 [0.81-1.26],0.918555895242247,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.99 [0.78-1.25],0.919931158475256,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PALM2,Paralemmin-2,Inverse variance weighted,9,0.99 [0.88-1.12],0.921674591740423,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.97 [0.51-1.84],0.921970768835797,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.99 [0.78-1.25],0.924990468471284,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.97 [0.5-1.87],0.925517085548741,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.99 [0.78-1.25],0.932125127262628,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.99 [0.8-1.23],0.932663595882553,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1.01 [0.85-1.19],0.933900163847711,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.99 [0.81-1.22],0.936081412382828,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1 [0.88-1.12],0.936598776053663,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.98 [0.62-1.56],0.936737300009294,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.63-1.52],0.937117861535021,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.01 [0.85-1.2],0.937263544034245,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,GAST,Gastrin,Inverse variance weighted,9,1.01 [0.84-1.2],0.938530552509345,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1 [0.93-1.07],0.939626299156341,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.99 [0.82-1.2],0.940430753572296,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,DCN,Decorin,Inverse variance weighted,2,0.98 [0.59-1.64],0.941399570757555,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.98 [0.6-1.62],0.945802962533171,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.01 [0.83-1.21],0.948648488594387,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.02 [0.6-1.73],0.950627397028622,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1 [0.88-1.14],0.951135914937674,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BGLAP,Osteocalcin,Inverse variance weighted,8,1.01 [0.81-1.25],0.952767102709321,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,LAYN,Layilin,Inverse variance weighted,3,0.98 [0.41-2.32],0.958289701377547,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.01 [0.66-1.55],0.959556251648769,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.01 [0.74-1.37],0.960374756989171,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1 [0.8-1.26],0.966499687049778,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1 [0.79-1.27],0.972350847116214,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1 [0.72-1.38],0.976776410808809,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1 [0.89-1.12],0.983898411379357,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1 [0.89-1.12],0.988387083879314,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1 [0.56-1.8],0.989456043357829,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.92-1.09],0.991128396629772,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1 [0.93-1.07],0.992976405347643,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,MMP3,Stromelysin-1,Inverse variance weighted,4,1 [0.67-1.5],0.996555559879451,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,AGRN,Agrin,Inverse variance weighted,14,1 [0.8-1.26],0.997860217337646,trans
Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,OGN,Mimecan,Inverse variance weighted,37,1 [0.94-1.06],0.998598293583907,trans
